NCT06590272

Brief Summary

The objective of this study was to compare the objective visual outcomes and subjective fuctional vision of four different intraocular lens (IOL) in patients underwent cataracts surgery. This was a retrospective study. Patients with age-related cataract underwent phacoemulsification combined with IOLs implantation. Patients were divided into 4 groups. Uncorrected distant visual acuity(UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA),and the best corrected visual acuity (BCVA) 1 month and 3 months after the surgery were determined. The defocus curve, contrast sensitivity, and customized VF-14-oriented Visual Function Index questionnaire were performed 3 months postoperatively. Kruskal-Wallis test and generalized estimating equation(GEE) were used to analyze and compare the difference between objective visual outcomes and subjective visual quality among different groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 31, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.7 years

First QC Date

August 31, 2024

Last Update Submit

September 5, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Postoperative visual acuity

    The uncorrected distant visual acuity(UDVA), the best corrected distant visual acuity (BCVA) (5 m), the uncorrected intermediate visual acuity(UIVA) (80 cm) and the uncorrected near visual acuity(UIVA) (40 cm) were chosen as the index to evaluate the VA. The UDVA and BCVA were examined by logarithmic visual acuity chart. The UIVA and UIVA were examined by using a near eye chart.They were all measured 1 month and 3 months after the surgery.

    3 months

  • Postoperative contrast sensitivity

    The contrast sensitivity was used to conduct the assessment by CSV-1000E (VectorVision, USA) under photopic (85 cd/m2) condition at a 2.5m distance. The logarithmic values for 3, 6, 12, and 18 cycles/degree (c/d) were analyzed 3 months postoperatively.

    3 months

  • Postoperative defocus curve

    Defocus curve was used to evaluate the visual quality of functional intraocular lens after surgery. The insertion range was -4.0 D \~ + 2.0 D, increasing by 0.5 D. The best corrected distant visual acuity was recorded at each diopter 3 months postoperatively.

    3 months

  • Postoperative eye-related quality of life

    Based on the American Questionnaire on Visual Function Index-14 (VF-14), the Chinese-oriented version(VF-12-CN) was used to investigate the postoperative near-vision, visual satisfaction, ocular discomfort, visual disturbance, and subjective feelings of far-vision, middle-vision and near-vision. Each question was divided into 4 levels and the scores ranked from 0 to 3 points. Considering the visual interference such as glare and halo, the evaluation of glare and halo visual interference phenomenon was also added.

    3 months after surgery

Study Arms (4)

TECNIS PCB00 IOL (A)

The patients in this groups underwent cataract surgery with TECNIS PCB00 IOL

Device: TECNIS PCB00 intraocular lens

HumanOptics Diff-Aay IOL (B)

The patients in this groups underwent cataract surgery with HumanOptics Diff-Aay IOL

Device: HumanOptics Diff-Aay intraocular lens

TECNIS Symfony ZXR00 IOL (C)

The patients in this groups underwent cataract surgery with TECNIS Symfony ZXR00 IOL

Device: TECNIS Symfony ZXR00 intraocular len

ZEISS AT LISA tri 839MP IOL (D)

The patients in this groups underwent cataract surgery with ZEISS AT LISA tri 839MP IOL

Device: ZEISS AT LISA tri 839MP intraocular len

Interventions

In this study, we select TECNIS PCB00 IOL for inserting in the eyes during the cataract surgery

Also known as: IOL
TECNIS PCB00 IOL (A)

In this study, we select HumanOptics Diff-Aay IOL for inserting in the eyes during the cataract surgery

Also known as: IOL
HumanOptics Diff-Aay IOL (B)

In this study, we select TECNIS Symfony ZXR00 IOL for inserting in the eyes during the cataract surgery

Also known as: IOL
TECNIS Symfony ZXR00 IOL (C)

In this study, we select ZEISS AT LISA tri 839MP IOL for inserting in the eyes during the cataract surgery

Also known as: IOL
ZEISS AT LISA tri 839MP IOL (D)

Eligibility Criteria

Age50 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cataract ultrasonic emulsification aspiration with one-stage implantation of 4 types of IOLs at the Shanghai Tenth People\'s Hospital from October 2021 to June 2023

You may qualify if:

  • age-related cataract with myopia≤-6.0D and over 0.0D
  • axial length≤26mm and corneal astigmatism≤1.5D
  • well-cooperation of finishing preoperative examinations
  • completion of all follow-up visits

You may not qualify if:

  • previous eye diseases that affect vision including keratopathy, glaucoma, uveitis, amblyopia, fundus diseases, etc.
  • patients with decreased cognitive ability, unable to cooperate with preoperative examination, or suffering from severe anxiety, depression and mental illness
  • serious complications during operation, including corneal injury, iris injury, expelling choroidal hemorrhage, posterior capsule rupture, etc
  • serious postoperative complications, including displacement of intraocular lens, macular edema, endophthalmitis, etc
  • follow-ups less than 3months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai 10th People's Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Yiwen Hu

    Shanghai 10th People's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician

Study Record Dates

First Submitted

August 31, 2024

First Posted

September 19, 2024

Study Start

October 1, 2021

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations